Do you want to read an article? Please log in or register.
Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy
Inflamm Bowel Dis.
Chen C, Hartzema AG, Xiao H, Wei YJ, Chaudhry N, Ewelukwa O, Glover SC, Zimmermann EM
doi: 10.1093/ibd/izz001.
Inflammatory Bowel Disease
Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases
Inflamm Bowel Dis.
Attauabi M, Zhao M, Bendtsen F, Burisch J
doi: 10.1093/ibd/izaa167.
Inflammatory Bowel Disease
Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease
Inflamm Bowel Dis.
Shah NB, Haydek J, Slaughter J, Ashton JR, Zuckerman AD, Wong R, Raffa F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu DB, Schwartz D, Horst SN
doi: 10.1093/ibd/izz253.
RECOMMENDED
Inflammatory Bowel Disease
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 y Before Diagnosis
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology.
Torres J, Petralia F, Sato T, Wang P, Telesco SE, Choung RS, Strauss R, Li XJ, Laird RM, Gutierrez RL, Porter CK, Plevy S, Princen F, Murray JA, Riddle MS, Colombel JF
doi: 10.1053/j.gastro.2020.03.007.
Inflammatory Bowel Disease
Injury Characteristics and Outcomes of Patients With Inflammatory Bowel Disease After Trauma: A Propensity Score Matched Analysis
Inflamm Bowel Dis.
Haac BE, Nemirovsky A, Teeter W, Geyer A, Birkett RT, Cross RK, Engels M, Stein DM, Bafford AC
doi: 10.1093/ibd/izz254.
Inflammatory Bowel Disease
The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis
BMC Gastroenterol.
Chen Y, Chen L, Xing C, Deng G, Zeng F, Xie T, Gu L, Yang H
doi: 10.1186/s12876-020-01339-3.
Inflammatory Bowel Disease
Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis
Clin Gastroenterol Hepatol.
Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ
doi: 10.1016/j.cgh.2019.02.044.
Inflammatory Bowel Disease
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
United European Gastroenterol J.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A
doi: 10.1177/2050640620929133.
Inflammatory Bowel Disease
Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases
Inflamm Bowel Dis.
Dalal RS, Palchaudhuri S, Snider CK, Lewis JD, Mehta SJ, Lichtenstein GR
doi: 10.1093/ibd/izaa104.